She is a Chair of the International Pharmaceutical Federation (FIP) Special Interest Group on Personalised and Precision Medicine and a Chair for the Oncology Special Interest Group within the Pharmacogenomics Global Research Network (PGRN). She serves on the editorial board of Annals of Translational Medicine and Frontiers in Pharmacology. To date, she has published over 100 peer-reviewed research papers many of which are in high caliber journals, e.g., Nature, Nature Medicine, PNAS, Blood, Cancer Research, Genome Biology and American Journal of Human Genetics. Dr. Huang is a board certified clinical pharmacologist with extensive training in genetics, molecular and cell biology, clinical trials and high throughput data analysis.